Paweł Rajewski | Cardiovascular risk | Best Research Article Award | Best Research Article Award

🏥Current Position and Roles:

Dr. Paweł Rajewski is a distinguished medical doctor, professor, and the rector of the Faculty of Health Sciences at the University of Health Sciences in Bydgoszcz. He holds the vital role of Provincial Consultant in Infectious Diseases for the Kuyavian-Pomeranian Voivodeship, providing oversight and strategic insights on infectious disease management in the region. Dr. Rajewski serves as the Head of the Department of Internal Medicine and Infectious Diseases at the Tadeusz Browicz Provincial Infectious Disease Hospital in Bydgoszcz, as well as the Head of the Liver, Internal, Infectious, and Metabolic Disorders Clinic at CM Gizińscy in Bydgoszcz. Previously, he served as the Medical Director and Head of the Department of Internal Medicine and Hepatology at the Emil Warmiński Multispecialist City Hospital. Through these roles, he contributes to the health of countless patients while also shaping medical policy and practice.

🎓Academic Background:

Dr. Rajewski’s academic journey has been marked by an enduring commitment to medicine, specializing in areas such as internal medicine, infectious diseases, hepatology, and clinical transplantation. His qualifications in these areas form the bedrock of his clinical and academic expertise, enabling him to deliver high-impact research and patient care in fields that are central to public health. Dr. Rajewski’s education includes specialty certifications as a lipidologist, accredited by the Polish Lipid Association, and an obesitologist with certifications from the Polish Association for the Study of Obesity and the Polish Society for Obesity Treatment.

📚Research Interests and Publication Achievements: 

Dr. Rajewski has contributed over 200 articles, primarily focused on metabolic disorders, obesity, liver diseases, and cardiovascular risk factors. His work, published in reputed medical journals, has been instrumental in advancing knowledge on these critical health issues. His research sheds light on complex metabolic processes, influencing both preventive and therapeutic approaches to conditions like non-alcoholic fatty liver disease and atherosclerosis. His publications are widely recognized for their scientific rigor and relevance, contributing to his esteemed reputation in the medical research community.

🔬Ongoing Research Projects:

Dr. Rajewski is currently engaged in various research projects that address emerging concerns in metabolic health and infectious diseases. His work on liver disease mechanisms and cardiovascular risk factors associated with obesity and metabolic syndrome aims to uncover better diagnostic markers and treatment pathways. A recent focus involves studying COVID-19’s impact on liver function and the interplay between viral infections and metabolic health, topics highly relevant in today’s healthcare landscape.

👥Professional Associations and Certifications: 

Dr. Rajewski’s memberships in prestigious medical associations, including the Polish Lipid Association and the Polish Association for the Study of Obesity, underscore his dedication to staying at the forefront of medical science. His certified expertise as a lipidologist and obesitologist enables him to approach health issues with a comprehensive understanding of lipid and metabolic disorders, enhancing the efficacy of treatments and preventive measures.

🏆Scholarships and Awards: 

Dr. Rajewski’s contributions to medicine have earned him numerous accolades, recognizing his achievements in research and clinical practice. These awards celebrate his innovation in metabolic research and his pivotal role in infectious disease management. His scholarship funding reflects a legacy of excellence and a commitment to advancing medical science.

📖Training & Workshops Attended:

In his pursuit of continual growth, Dr. Rajewski has attended a series of specialized workshops on bioinformatics, advanced diagnostics, and clinical applications in infectious disease management. These workshops equip him with cutting-edge skills that he applies to his daily work, benefiting patients and enhancing the training of his medical students.

💻Contributions to Bioinformatics and Clinical Research: 

A proficient bioinformatician, Dr. Rajewski integrates data science and computational tools in his research on metabolic diseases and infectious pathogens. By utilizing bioinformatics, he has been able to analyze complex datasets, leading to insights into genetic predispositions and disease progression. His ability to harness bioinformatics tools strengthens his work in both metabolic and infectious disease studies, positioning him at the cutting edge of medical research.

🎤Oral Presentations and Conferences: 

As a frequent presenter at national and international conferences, Dr. Rajewski shares his research findings with the medical community. His presentations cover topics like liver disease pathogenesis, metabolic syndrome treatments, and emerging infectious diseases. He contributes actively to knowledge exchange, with his lectures serving as valuable learning resources for both peers and students.

📊Key Tasks and Responsibilities as a Researcher:

In his research role, Dr. Rajewski coordinates multi-disciplinary teams, designing studies, and conducting extensive data analyses. His responsibilities include overseeing clinical trials and ensuring the ethical integrity of research protocols. His dedication to stringent research standards has led to significant findings that improve patient care protocols and inform public health strategies.

🌠Success Factors:

Dr. Rajewski attributes his success to his commitment to continuous learning, innovation, and collaboration. His ability to bridge theoretical research with practical applications in healthcare makes his contributions exceptionally valuable. Additionally, his leadership in the clinical setting exemplifies his holistic approach to healthcare, balancing research with direct patient care.

🔍Publications & Laboratory Experience:

Dr. Rajewski’s extensive laboratory experience includes advanced diagnostics in liver diseases, where he employs innovative techniques to diagnose and manage conditions like hepatitis and liver fibrosis. His publications detail his findings on the effectiveness of new biomarkers, offering insights that enhance both diagnostics and treatment options for liver and metabolic disorders.

🌐Conclusion: 

Dr. Paweł Rajewski’s career exemplifies a dedication to excellence in medicine, research, and public health. His multifaceted expertise in internal medicine, infectious diseases, and metabolic health has propelled him to the forefront of healthcare in Poland. Dr. Rajewski’s contributions are invaluable to the fields of hepatology and infectious disease, positively impacting patient care and advancing medical knowledge. Through his foundation, research, and clinical roles, he continues to shape the future of health sciences, creating a lasting legacy of compassion, knowledge, and innovation.

 

Top Notable Publications:

 

Hepatitis C Infection Is Not a Cardiovascular Risk Factor in Young Adults

Authors: Not listed; need to check for full author details.

Year: 2024

Citation: Biomedicines, 2024, 12(10), article 2400. DOI: 10.3390/biomedicines12102400.

Feasibility and Cardiometabolic Effects of Time-Restricted Eating in Patients with Metabolic Syndrome

Authors: Not listed; need to check for full author details.

Year: 2024

Citation: Nutrients, 2024, 16(12), article 1802. DOI: 10.3390/nu16121802.

Hepatitis C Infection as a Risk Factor for Hypertension and Cardiovascular Diseases: An EpiTer Multicenter Study

Authors: Not listed; need to check for full author details.

Year: 2022

Citation: Journal of Clinical Medicine, 2022, 11(17), article 5193. DOI: 10.3390/jcm11175193.

The Dynamics of Changes in the Concentration of IgG against the S1 Subunit in Polish Healthcare Workers in the Period from 1 to 12 Months after Injection, Including Four COVID-19 Vaccines

Authors: Not listed; need to check for full author details.

Year: 2022

Citation: Vaccines, 2022, 10(4), article 506. DOI: 10.3390/vaccines10040506.

HCV Genotype Has No Influence on the Incidence of Diabetes—EpiTer Multicentre Study

Authors: Not listed; need to check for full author details.

Year: 2022

Citation: Journal of Clinical Medicine, 2022, 11(2), article 379. DOI: 10.3390/jcm11020379.

Anti-SARS-CoV-2 IgG against the S Protein: A Comparison of BNT162b2, mRNA-1273, ChAdOx1 nCoV-2019 and Ad26.COV2.S Vaccines

Authors: Not listed; need to check for full author details.

Year: 2022

Citation: Vaccines, 2022, 10(1), article 99. DOI: 10.3390/vaccines10010099.

Pilot Clinical Trial of Time-Restricted Eating in Patients with Metabolic Syndrome

Authors: Not listed; need to check for full author details.

Year: 2021

Citation: Nutrients, 2021, 13(2), article 346. DOI: 10.3390/nu13020346.

Resveratrol’s Impact on Vascular Smooth Muscle Cells Hyporeactivity: The Role of Rho-Kinase Inhibition

Authors: Not listed; need to check for full author details.

Year: 2020

Citation: BioMed Research International, 2020, article 9012071. DOI: 10.1155/2020/9012071.

Zakażenie wirusem cytomegalii w praktyce klinicznej – diagnostyka, objawy i leczenie w świetle aktualnej wiedzy

Authors: Not listed; need to check for full author details.

Year: 2019

Citation: Forum Zakażeń, 2019, issue 4, article FZ2019042. DOI: 10.15374/FZ2019042.

Melatonin Supplementation Lowers Oxidative Stress and Regulates Adipokines in Obese Patients on a Calorie‐Restricted Diet

Authors: Not listed; need to check for full author details.

Year: 2017

Citation: Oxidative Medicine and Cellular Longevity, 2017, article 8494107. DOI: 10.1155/2017/8494107.

Zaid Al jebaje | Interventional Cardiology | Best Researcher Award

🎓Current Position:

Dr. Zaid Al-Jebaje is currently engaged in his role at Toledo Cardiology Consultants since July 2024. Prior to this, he completed his fellowship in complex, high-risk, and indicated percutaneous interventions at the Henry Ford Health System in Detroit, Michigan. This fellowship emphasized intricate coronary and peripheral interventions, chronic total occlusions, and mechanical support, reflecting his advanced skill set in interventional cardiology. His education and clinical training have equipped him with a robust foundation for delivering high-quality cardiovascular care.

📚Academic Background:

Dr. Al-Jebaje earned his MBChB from the University of Baghdad College of Medicine in Iraq (2006-2012). He completed his Internal Medicine Residency at the University at Buffalo – Catholic Health System (2016-2019) and subsequently pursued a Cardiovascular Fellowship at the University of Rochester – Strong Memorial Hospital. He further specialized with an Interventional Cardiology Fellowship at the Henry Ford Health System (2019-2023). His extensive education has provided him with the theoretical knowledge and practical skills necessary to excel in his field

📝Publication Achievements:

Dr. Al-Jebaje has an impressive publication record, contributing to over 16 peer-reviewed articles in prominent medical journals. His research covers a diverse array of topics in cardiology, including innovative techniques in transcatheter aortic valve replacement (TAVR) and the management of cardiac conditions. Some notable publications include:

  1. Outcomes following TAVR in patients with cardiogenic shock (2024) – A systematic review and meta-analysis that highlights significant findings in cardiac intervention.
  2. Retrospective Multicenter Analysis of Intravascular Lithotripsy during imaging-guided interventions, published in the Journal of Society of Cardiovascular Angiography and Intervention (2023).
  3. Liberal versus Conservative Transfusion Strategy for Patients with Acute Myocardial Infarction and Anemia (2023) – This systematic review and meta-analysis provides insights into transfusion practices.

Dr. Al-Jebaje’s dedication to research is further illustrated by his involvement in ongoing clinical trials and investigations, continually striving to advance the field of cardiology.

 

🔬Ongoing Research and Research Interests:

Dr. Al-Jebaje’s ongoing research focuses on the efficacy of new interventional techniques and the optimization of patient outcomes in complex cardiac scenarios. His specific interests include:

  • Complex Coronary Interventions: Investigating the best practices for treating patients with chronic total occlusions.
  • Transcatheter Therapies: Exploring advancements in minimally invasive procedures to improve cardiac health.
  • Cardiogenic Shock Management: Evaluating innovative strategies in treating patients experiencing severe heart failure.

These areas reflect his commitment to enhancing the understanding and treatment of cardiovascular diseases, aiming for improved patient care and outcomes.

🤝Professional Associations:

He is an active member of several professional organizations in the field of cardiology, which provide him with platforms for collaboration, continuing education, and sharing advancements in cardiac care. These associations include:

  • American College of Cardiology (ACC)
  • Society for Cardiovascular Angiography and Interventions (SCAI)

These memberships enable him to stay updated on the latest clinical guidelines and innovations in cardiovascular medicine.

🏆Awards and Scholarships 

Throughout his educational journey, Dr. Al-Jebaje has been recognized for his academic excellence and research contributions. While specific awards were not listed, his multiple certifications from the American Board of Interventional Cardiology and other specialties underscore his commitment to lifelong learning and professional development.

🎤Oral Presentations:

He has also delivered several oral presentations at notable conferences, including the SCAISHOCK Conference in Minneapolis (October 2022), where he presented his work on TransCaval LAVA ECMO in cardiogenic shock. Such presentations highlight his role as a thought leader in cardiology, sharing insights and findings with peers in the medical community.

🎓Training & Workshops 

Dr. Al-Jebaje frequently participates in workshops and training sessions to refine his skills and keep abreast of the latest techniques in interventional cardiology. This commitment to ongoing education is essential in a rapidly evolving field like cardiology.

🧪Laboratory Experience and Success Factors:

His extensive publications reflect not only his research proficiency but also his laboratory experience, where he has developed a deep understanding of cardiac physiology and intervention techniques. He is committed to translating his findings into clinical practice, aiming for better outcomes in patient care.

Dr. Al-Jebaje attributes his success to a combination of factors:

  • Dedication to Patient Care: Always prioritizing the well-being of his patients.
  • Continuous Learning: Actively engaging in professional development to enhance his skills.
  • Collaboration: Working alongside leading professionals in cardiology to foster innovation.

🛠️Tasks Completed as a Researcher:

As a researcher, Dr. Al-Jebaje has successfully managed various projects, from clinical trials to meta-analyses, contributing to the advancement of cardiovascular knowledge. His ability to work collaboratively within multidisciplinary teams has led to significant findings that influence clinical practice.

 

🌍Conclusion:

In summary, Dr. Zaid Al-Jebaje stands out as a dedicated interventional cardiologist with a wealth of knowledge and experience in complex cardiovascular interventions. His ongoing research, extensive publication record, and commitment to professional development underscore his influence in the field of cardiology. With a focus on improving patient outcomes and advancing cardiac care, he continues to be a vital contributor to medical science and the healthcare community.

 

Top Notable Publications:
  • Article Title: Galectin-3 Predicts Long-Term Risk of Cerebral Disability and Mortality in Out-of-Hospital Cardiac Arrest Survivors
    Authors: Abdelradi, A., Mosleh, W., Kattel, S., Pokharel, S., Sharma, U.C.
    Journal: Journal of Personalized Medicine
    Year: 2024
    Volume: 14
    Issue: 9
    Article Number: 994
    Citations: 0
  • Article Title: Retrospective Multicenter Analysis of Intravascular Lithotripsy Use During Calcified Left Main Coronary Artery Percutaneous Coronary Interventions
    Authors: Riley, R.F., Miller, L.E., Davies, R., Dakroub, A., Ali, Z.A.
    Journal: Journal of the Society for Cardiovascular Angiography and Interventions
    Year: 2024
    Volume: 3
    Issue: 2
    Article Number: 101213
    Citations: 1
  • Article Title: Outcomes following TAVR in patients with cardiogenic shock: A systematic review and meta-analysis
    Authors: Jabri, A., Ayyad, M., Albandak, M., AlQarqaz, M., Villablanca, P.
    Journal: Cardiovascular Revascularization Medicine
    Year: 2024
    Citations: 0
  • Article Title: Galectin-3 as a risk predictor of mortality in survivors of out-of-hospital cardiac arrest
    Authors: Mosleh, W., Kattel, S., Bhatt, H., Chaudhari, M.R., Sharma, U.C.
    Journal: Circulation: Arrhythmia and Electrophysiology
    Year: 2019
    Volume: 12
    Issue: 10
    Article Number: e007519
    Citations: 6
  • Article Title: Spinal tophaceous gout presenting in a young adult without pain
    Authors: Al-Jebaje, Z., Elibol, J.M., Peters, J., Alameri, A.
    Journal: BMJ Case Reports
    Year: 2018
    Article Number: 224406
    Citations: 5